|Drug Name:||Timolol Maleate|
|Manufacturer:||Bausch & Lomb Incorporated|
|Other Info:||Bausch & Lomb IncorporatedTampa, FL 33637©Bausch & Lomb Incorporated9071900 (Folded) 9072000 (Flat)|
Timolol maleate ophthalmic solution is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.
Intraocular pressure disorder
-- A condition in which the intraocular pressure is elevated above normal and which may lead to glaucoma.
Open Angle Glaucoma
-- Glaucoma in which the angle of the anterior chamber is open and the trabecular meshwork does not encroach on the base of the iris.
Timolol maleate is contraindicated in patients with (1) bronchial asthma; (2) a history of bronchial asthma; (3) severe chronic obstructive pulmonary disease (see WARNINGS); (4) sinus bradycardia; (5) second or third degree atrioventricular block; (6) overt cardiac failure (see WARNINGS; (7) cardiogenic shock; or (8) hypersensitivity to any component of this product.
-- A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).
-- inability of the heart to pump blood at an adequate rate to fill tissue metabolic requirements or the ability to do so only at an elevated filling pressure.
-- Shock resulting from diminution of cardiac output in heart disease.
-- Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen.
As with many topically applied ophthalmic drugs, this drug is absorbed systemically.The same adverse reactions found with systemic administration of beta-adrenergic blocking agents may occur with topical administration.
For example, severerespiratory reactions and cardiac reactions, including death due to bronchospasm in patients with asthma, and rarely death in association with cardiac failure, havebeen reported following systemic or ophthalmic administration of timolol maleate (see CONTRAINDICATIONS).
This web-site is for informational purposes only and is not intended as a substitute for advice from your doctor.
It should not to be used for self-diagnosis or treatment.